Working paper

How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing?

Theory and Experiment

David Bardey, Philippe De Donder, and Cesar Mantilla

Abstract

We compare two genetic testing regulations, Disclosure Duty (DD) and Consent Law (CL), in an environment where individuals choose to take a genetic test or not. DD forces agents to reveal the test results to their insurers, resulting in a discrimination risk. CL allows agents to withhold that information, generating adverse selection. We complement our model with an experiment. We obtain that a larger fraction of agents test under CL than under DD, and that the proportion of individuals preferring CL to DD is non-monotone in the test cost when adverse selection is set endogenously at its steady state level.

Keywords

Consent Law; Disclosure Duty; Personalised Medicine; Test take up rate; pooling health insurance contracts;

JEL codes

  • C91: Laboratory, Individual Behavior
  • D82: Asymmetric and Private Information • Mechanism Design
  • I18: Government Policy • Regulation • Public Health

Replaced by

David Bardey, Philippe De Donder, and Cesar Mantilla, “How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment”, Journal of Health Economics, vol. 68, December 2019, p. 102223.

Reference

David Bardey, Philippe De Donder, and Cesar Mantilla, “How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing?: Theory and Experiment”, TSE Working Paper, n. 17-777, March 2017, revised July 2019.

See also

Published in

TSE Working Paper, n. 17-777, March 2017, revised July 2019